KEC International Peer Comparison

NSE: KEC | BSE: 532714

₹334.00

₹-9.55 (-2.78%)

As on 21-Oct-2026IST

Market cap

₹8,883 Cr

Revenue (TTM)

₹23,506 Cr

P/E Ratio

P/B Ratio

1.4

Div. Yield

1.7 %

Edit

	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Market cap (₹ Cr)	8,883	340	213	60	39
Revenue (₹ Cr)	23,506	82	434	67	181
Net Profit (₹ Cr)	553.62	10.62	17.44	-7.30	2.66
Net Margin (%)	2.35	12.59	3.90	0.51	1.42
RoE (%)	10.18	9.30	6.80	-47.21	2.82
Price to Earnings	16.05	31.98	12.24	--	18.78
Price-To-Book	1.43	2.73	0.82	24.37	0.54

Income Statement (₹ Cr)

	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Operating Revenue	23,505.54	80.43	430.87	61.87	130.23
Total Income	23,662.81	83.18	442.48	63.37	133.35
Total Expenditure	21,745.77	64.21	407.51	57.54	123.85
EBITDA	1,759.77	16.22	23.37	4.33	6.38
Depreciation	197.38	4.38	10.92	2.76	3.37
EBIT	1,562.39	11.84	12.45	1.57	3.01
Interest	871.74	0.56	12.97	0.79	11.88
Other Income	157.27	2.75	11.60	1.50	3.13
Exceptional Items	-58.78	-0.60	11.95	0.09	--
Profit before Tax	789.14	13.44	11.08	-0.99	-5.74
Provision for Tax	183.55	3.63	1.61	0.08	0.36
Profit after Tax	605.59	9.81	9.47	-1.06	-6.11

	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Shareholder's Funds	6,159.69	122.45	257.94	2.31	72.51
Minority Interest	--	--	--	--	27.41
Non-Current Liabilities	515.16	2.31	68.01	8.14	65.54
Current Liabilities	18,007.82	9.40	236.55	55.00	102.48
Total Liabilities	25,133.45	134.69	567.57	68.45	267.94

	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Non-Current Assets	2,473.59	75.09	313.41	39.29	90.00
Current Assets	22,209.08	59.07	249.09	26.27	177.94
Total Assets	25,133.45	134.69	567.57	68.45	267.94
Total Debt*	5,103.23	2.43	148.60	39.12	137.07
Net Current Assets	4,201.26	49.67	12.55	-28.73	75.45
Contingent Liabilities	188.22	2.67	16.95	4.61	--

	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Cash From Operating Activities	-414.12	12.08	14.25	0.66	-6.74
Cash Flow from Investing Activities	-241.80	-10.09	-8.24	-9.76	24.74
Cash from Financing Activities	510.97	-5.36	-3.75	9.44	-18.30
Net Cash Inflow / Outflow	-144.95	-3.37	2.26	0.34	-0.29

	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
ROCE (%)	16.35	11.43	6.08	-0.48	3.19
ROE (%)	10.53	8.31	3.76	-12.57	-9.25
ROA (%)	2.61	7.52	1.74	-1.56	-2.44
EBIT Margin (%)	8.16	23.59	8.12	9.42	7.30
Net Margin (%)	2.56	11.79	2.14	-1.68	-4.58
Cash Profit Margin (%)	3.42	17.64	4.72	2.75	-2.10

	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Revenue Growth (%)	7.59	16.72	-2.78	10.80	-21.66
EBIT Growth (%)	9.54	18.11	-3.51	33.58	-61.80
Net Profit Growth (%)	6.11	27.10	-64.58	-250.62	-158.60
EPS Growth (%)	6.11	27.10	-64.58	-2.64	-124.45
Book Value Growth (%)	15.19	7.79	5.20	-84.21	9.39

	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Price / Earnings	22.49	13.36	18.22	0.00	0.00
Price / Book Value	2.21	1.07	0.67	21.65	0.94
Dividend Yield (%)	1.08	0.91	0.00	0.00	0.00
EV/EBITDA	9.50	6.00	9.09	15.18	21.23
Market Cap (₹ Cr)	13,619.11	131.05	172.48	49.91	64.93

	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Debt to Equity	0.83	0.02	0.58	16.97	1.99
Short term debt to equity ratio	0.68	0.03	0.41	14.97	0.97
Current Ratio	1.23	6.28	1.05	0.48	1.74
Quick Ratio	1.15	4.84	0.60	0.33	1.33
Interest Coverage	1.91	25.20	1.85	-0.25	0.52

	KEC International	Tamboli Capital	Gillanders Arbuthnot	Delta Manuf	Indrayani Biotech
Debtors to sales (%)	27.54	27.55	14.66	19.80	45.07
Asset Turnover	1.01	0.62	0.80	0.91	0.52
Receivable days	89.48	87.30	52.78	79.88	137.64
Inventory Days	20.76	61.62	83.71	57.53	117.29
Payable days	238.84	135.35	179.84	149.50	134.44
Cash Conversion Cycle	-128.60	13.57	-43.36	-12.09	120.49

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.